4-(4-Chlorophenyl)-3h,4h,5h,6h,7h-imidazo[4,5-c]pyridine, 97%, 1g

7-Bromo-2,4-dichloro-8-fluoro-6-iodoquinazoline, 98%, 1g

2-Bromo-5-isopropoxypyridine, 95.0%, 5g

Vial de reacción con brida plana, cilíndrico, graduado, con camisa protectora, pieza de conexión GL, DN 60, 100 ml, 90 mm, 1 pieza

1-(3-Bromo-4-(1H-imidazol-1-yl)phenyl)ethanone, 95.0%, 5g

1-Ethyl-7-(methylsulfonyl)-1H-pyrimido[4,5-d][1,3]oxazin-2(4H)-one, 95%, 1g

tert-butyl 3-oxo-1H,2H,3H,4H,5H,6H,7H,8H-pyrazolo[3,4-c]azepine-7-carboxylate, 95+%, 100mg

2-(Difluoromethoxy)toluene, 97%, 5g

Hesperidin>90.0%(HPLC)(T)500g

6-Bromonaphthalen-2-amine hydrochloride, 95.0%, 25g

tert-Butyl 4-(2-methylphenyl)piperazine-1-carboxylate, 98%, 5g

Methyl 1-oxo-1,2-dihydroisoquinoline-3-carboxylate, 95.0%, 1g

2-(2-Chloroethyl)-1h-1,3-benzodiazole hydrochloride, 95+%, 100mg